Norway · Delayed Price · Currency is NOK Observe Medical ASA Earnings Call Transcripts
Fiscal Year 2026
-
Sales grew 80% year-on-year, driven by new product launches and expanded distribution, with the business now present in 46 countries and targeting a NOK 2.6 billion market. The company expects to reach cash positivity this year and continues to innovate with products like UnoMeter Safeti Max.
Fiscal Year 2025
-
Oona Meter products saw 61% growth and expanded to 44 countries, with order intake surpassing NOK 25 million. New infection control innovations and product launches are on track, while significant debt reduction and a new investor have strengthened financials.
-
A robust proprietary and partnered product strategy has positioned the business as a leader in urine output measurement, with a strong global distribution network and accelerating order intake. Key product launches and debt restructuring agreements support ambitions for profitability and growth.
Fiscal Year 2024
-
H1 2024 saw NOK 13.1 million in revenue and a gross margin of 38.2%, with the launch of UnoMeter Safeti Plus expected to drive future growth. A NOK 22 million private placement strengthened liquidity, and new partnerships and product launches are set to expand market reach.